Micafungin Enhances the Human Macrophage Response to Candida albicans through β-Glucan Exposure

Antimicrobial Agents and Chemotherapy
José P Guirao-AbadMaría Martínez-Esparza

Abstract

Micafungin belongs to the antifungal family of echinocandins, which act as noncompetitive inhibitors of the fungal cell wall β-1,3-d-glucan synthase. Since Candida albicans is the most prevalent pathogenic fungus in humans, we study the involvement of micafungin in the modulation of the inflammatory response developed by human tissue macrophages against C. albicans The MIC for micafungin was 0.016 μg/ml on the C. albicans SC5314 standard strain. Micafungin induced a drastic reduction in the number of exponential SC5314 viable cells, with the fungicidal effect being dependent on the cellular metabolic activity. Notably, micafungin also caused a structural remodelling of the cell wall, leading to exposure of the β-glucan and chitin content on the external surface. At the higher doses used (0.05 μg/ml), the antifungal also induced the blowing up of budding yeasts. In addition, preincubation with micafungin before exposure to human tissue macrophages enhanced the secretion of tumor necrosis factor alpha (TNF-α), interleukin-17A (IL-17A), and IL-10 cytokines. Our results strongly suggest that in C. albicans treatment with micafungin, in addition to having the expected toxic antifungal effect, it potentiates the immune response, impr...Continue Reading

References

Mar 12, 2005·Cellular Microbiology·Gordon D Brown, Siamon Gordon
May 3, 2006·PLoS Pathogens·Robert T Wheeler, Gerald R Fink
Mar 16, 2007·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·M Martínez-EsparzaJ C Argüelles
Nov 20, 2009·Journal of Clinical Microbiology·M A PfallerD J Diekema
Nov 10, 2010·International Immunology·Sanne P SmeekensMihai G Netea
Dec 24, 2010·Drugs·Sharon C-A ChenTania C Sorrell
Feb 12, 2011·Microbes and Infection·Fernanda Sangalli-LeiteOscar Zaragoza
Apr 30, 2011·Future Microbiology·David S Perlin
Dec 16, 2011·Acta Dermato-venereologica·Gerd G GauglitzHans C Korting
Feb 15, 2014·Cellular and Molecular Life Sciences : CMLS·Brigitte M E HayesMark R Bleackley
Jun 20, 2014·The Journal of Antimicrobial Chemotherapy·Laura Judith Marcos-ZambranoJesús Guinea
Aug 6, 2014·Intensive Care Medicine·Danièle MaubonMuriel Cornet
Jun 3, 2015·Mycoses·Maurizio SanguinettiCornelia Lass-Flörl
Oct 25, 2016·Current Infectious Disease Reports·Nathan P Wiederhold
Feb 10, 2017·Archives of Toxicology·C C ChangS C-A Chen
Apr 17, 2017·International Journal of Medical Microbiology : IJMM·José P Guirao-AbadJuan-Carlos Argüelles
Jun 2, 2017·JCI Insight·Michail S LionakisTobias M Hohl

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Aspergillosis (ASM)

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

Aspergillosis

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.